Active Ingredient: LANDIOLOL HYDROCHLORIDE
Proprietary Name: RAPIBLYK
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 280MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217202
Product Number: 001
Approval Date: Nov 22, 2024
Applicant Holder Full Name: AOP ORPHAN PHARMACEUTICALS AG
Marketing Status:
Prescription
Patent and Exclusivity Information